From a translational standpoint, IL-18-targeted strategies may be valuable in preventing or treating heart failure.4, 23 An IL-18-blocking antibody and recombinant IL-18 binding protein, which binds circulating IL-18 preventing it from binding to the membrane receptor, are being developed as clinical therapeutics. This evidence concerns the gene IL18 and heart failure.